Kincell Bio · 1 day ago
Contingent Worker, Office & HR Coordinator
Kincell Bio is a contract development and manufacturing organization focused on engineering cells into therapies. The Contingent Office and HR Coordinator will manage office coordination and provide administrative support for the Human Resources and Executive Leadership teams, including event planning, managing office logistics, and assisting with HR functions.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Work with employee-led activity groups to schedule and organize events
Maintain and order site refreshments, office supplies, swag items, and office services
Assist executive staff with travel arrangements, reimbursements, and scheduling
Assist in coordinating and hosting site visits, and managing meeting logistics such as invitations, room reservations, and catering
Organize and prepare slide deck and materials for meetings such as town halls
Send site-wide and company-wide communications relating to site visits, employee engagement activities, etc
Serve as administrator for HR department platforms and admin processes
Assist staff with routine HR questions
Coordinate new employee onboarding and communications
Assist with special projects as needed to support quarterly department goals
Qualification
Required
Bachelor's degree or equivalent work experience
5+ years' experience in office management, executive administration, or human resources
Excellent communication skills and strong collaborator
Demonstrated ability to maintain confidential employee and business information
Proficiency in MS Office
Exceptionally detail oriented
Consistent in following processes and procedures
Preferred
Availability to be office-based at the Gainesville, FL site
Benefits
Competitive benefits
Company
Kincell Bio
Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding.
Funding
Current Stage
Growth StageTotal Funding
$58MKey Investors
Kineticos Ventures
2025-05-15Series Unknown· $22M
2023-07-26Series A· $36M
Recent News
2026-01-06
Precedence Research
2025-11-27
Company data provided by crunchbase